{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T06:08:17Z","timestamp":1780553297663,"version":"3.54.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2006,6,9]],"date-time":"2006-06-09T00:00:00Z","timestamp":1149811200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1007\/s00198-006-0157-3","type":"journal-article","created":{"date-parts":[[2006,6,8]],"date-time":"2006-06-08T14:46:27Z","timestamp":1149777987000},"page":"1524-1531","source":"Crossref","is-referenced-by-count":32,"title":["Teriparatide\u2019s effects on quantitative ultrasound parameters and bone density in women with established osteoporosis"],"prefix":"10.1007","volume":"17","author":[{"given":"S.","family":"Gonnelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Caffarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Salvadori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Cadirni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Montagnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Nuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,6,9]]},"reference":[{"key":"157_CR1","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1210\/er.2001-9002","volume":"23","author":"A Cranney","year":"2002","unstructured":"Cranney A, Guyatt G, Griffith L, Wells G, Tugwell P, Rosen C (2002) Meta-analyses of therapies for postmenopausal osteoporosis. IX. Summary of meta-analyses of therapies for postmenopausal osteoporosis. Endocr Rev 23:570\u2013578","journal-title":"Endocr Rev"},{"key":"157_CR2","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJM199412153312404","volume":"331","author":"JS Finkelstein","year":"1994","unstructured":"Finkelstein JS, Klibanski A, Schaefer EH, Hornstein MD, Schiff I, Neer RM (1994) Parathyroid hormone for prevention of bone loss induced by estrogen deficiency. N Engl J Med 331:1618\u20131623","journal-title":"N Engl J Med"},{"key":"157_CR3","first-page":"3069","volume":"85","author":"ES Kurland","year":"2000","unstructured":"Kurland ES, Cosman F, McMahon DJ, Rosen CJ, Lindsay R, Bilezikian JP (2000) Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers. J Clin Endocrinol Metab 85:3069\u20133076","journal-title":"J Clin Endocrinol Metab"},{"key":"157_CR4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1359\/jbmr.2003.18.1.9","volume":"18","author":"ES Orwoll","year":"2003","unstructured":"Orwoll ES, Scheele WH, Paul S, Adami S, Syversen U, Diez-Perz A, Kaufman JM, Clancy AD, Gaich GA (2003) The effect of teriparatide [human parathyroid hormone (1\u201334)] therapy on bone density in men with osteoporosis. J Bone Miner Res 18:9\u201317","journal-title":"J Bone Miner Res"},{"key":"157_CR5","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","volume":"344","author":"RM Neer","year":"2001","unstructured":"Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH (2001) Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434\u20131441","journal-title":"N Engl J Med"},{"key":"157_CR6","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1359\/jbmr.2003.18.3.539","volume":"18","author":"JR Zanchetta","year":"2003","unstructured":"Zanchetta JR, Bogado CE, Ferretti JL, Wang O, Wilson MG, Sato M, Gaich GA, Dalsky GP, Myers SL (2003) Effects of teriparatide [recombinant human parathyroid hormone (134)] on cortical bone in postmenopausal women with osteoporosis. J Bone Miner Res 18:539\u2013543","journal-title":"J Bone Miner Res"},{"key":"157_CR7","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00198-002-1312-0","volume":"14","author":"Q Rehman","year":"2003","unstructured":"Rehman Q, Lang TF, Arnaud CD, Modin GW, Lane NE (2003) Daily treatment with parathyroid hormone is associated with an increase in vertebral cross-sectional area in postmenopausal women with glucocorticoid-induced osteoporosis. Osteoporos Int 14:77\u201381","journal-title":"Osteoporos Int"},{"key":"157_CR8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1359\/jbmr.2001.16.1.157","volume":"16","author":"DB Burr","year":"2001","unstructured":"Burr DB, Hirano T, Turner CH, Hotchkiss C, Brommage R, Hock JM (2001) Intermittently administered human parathyroid hormone(134) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys. J Bone Miner Res 16:157\u2013165","journal-title":"J Bone Miner Res"},{"key":"157_CR9","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1359\/jbmr.2001.16.10.1846","volume":"16","author":"DW Dempster","year":"2001","unstructured":"Dempster DW, Cosman F, Kurland ES, Zhou H, Nieves J, Woelfert L, Shane E, Plavetic K, Muller R, Bilezikian J, Lindsay R (2001) Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study. J Bone Miner Res 16:1846\u20131853","journal-title":"J Bone Miner Res"},{"key":"157_CR10","doi-asserted-by":"crossref","unstructured":"Jiang Y, Zhao JJ, Mitlak BH, Wang O, Genant HK, Eriksen EF (2003) Recombinant human parathyroid hormone (1\u201334) [teriparatide] improves both cortical and cancellous bone structure. J Bone Miner Res 18:1932\u20131941","DOI":"10.1359\/jbmr.2003.18.11.1932"},{"key":"157_CR11","doi-asserted-by":"crossref","unstructured":"Adami S, Viapiana G, Gatti D (2004) Bone anabolic agents: the unanswered queries. Basic Clin Pharmacol Toxicol 94:257\u2013259","DOI":"10.1111\/j.1742-7843.2004.pto940601.x"},{"key":"157_CR12","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1359\/jbmr.040117","volume":"19","author":"B Ettinger","year":"2004","unstructured":"Ettinger B, San Martin J, Crans G, Pavo I (2004) Differential effects of teriparatide on bMD after treatment with raloxifene or alendronate. J Bone Miner Res 19:745\u2013751","journal-title":"J Bone Miner Res"},{"key":"157_CR13","doi-asserted-by":"crossref","unstructured":"Gluer CC, for the International Quantitative Ultrasound Consensus Group (1997) Quantitative ultrasound techniques for the assessment of osteoporosis: expert agreement on current status. J Bone Miner Res 12:1280\u20131288","DOI":"10.1359\/jbmr.1997.12.8.1280"},{"key":"157_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/PL00020939","volume":"12","author":"CF Njeh","year":"2001","unstructured":"Njeh CF, Fuerst T, Diessel E, Genant HK (2001) Is quantitative ultrasound dependent on bone structure? A reflection. Osteoporos Int 12:1\u201315","journal-title":"Osteoporos Int"},{"key":"157_CR15","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0140-6736(95)11456-4","volume":"348","author":"D Hans","year":"1996","unstructured":"Hans D, Dargent-Molina P, Schott AM, Sebert JL, Cormier C, Kotzki PO, Delmas PD, Pouilles JM, Breart G, Meunier PJ, for the EPIDOS prospective study group (1996) Ultrasonographic heel measurements to predict hip fracture in elderly women: the EPIDOS prospective study. Lancet 348:511\u2013514","journal-title":"Lancet"},{"key":"157_CR16","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1001\/archinte.1997.00440270067006","volume":"157","author":"DC Bauer","year":"1997","unstructured":"Bauer DC, Gluer CC, Cauley JA, Vogt TM, Ensrud KE, Genant HK, Black DM, for the study of osteoporotic fractures research group (1997) Broadband ultrasound attenuation predicts fractures strongly and independently of densitometry in older women: a prospective study. Arch Intern Med 157:629\u2013634","journal-title":"Arch Intern Med"},{"key":"157_CR17","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s001980200044","volume":"13","author":"D Mulleman","year":"2002","unstructured":"Mulleman D, Legroux-Gerot I, Duquesnoy B, Marchandise X, Delcambre B, Cortet B (2002) Quantitative ultrasound of bone in male osteoporosis. Osteoporos Int 13:388\u2013393","journal-title":"Osteoporos Int"},{"key":"157_CR18","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s00198-004-1771-6","volume":"16","author":"S Gonnelli","year":"2005","unstructured":"Gonnelli S, Cepollaro C, Gennari L, Montagnani A, Caffarelli C, Merlotti D, Rossi S, Cadirni A, Nuti R (2005) Quantitative ultrasound and dual-energy X-ray absorptiometry in the prediction of fragility fracture in men. Osteoporos Int 16:963\u2013968","journal-title":"Osteoporos Int"},{"key":"157_CR19","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s001980200018","volume":"13","author":"A Montagnani","year":"2002","unstructured":"Montagnani A, Gonnelli S, Cepollaro C, Bruni D, Franci MB, Lucani B, Gennari C (2002) Graphic trace analysis of quantitative ultrasound at phalanxes seems to improve the diagnosis of primary hyperparathyroidism among patients with low bone mass. Osteoporos Int 13:222\u2013227","journal-title":"Osteoporos Int"},{"key":"157_CR20","first-page":"483","volume":"9","author":"MA Krieg","year":"1999","unstructured":"Krieg MA, Jacquet AF, Bremgartner M, Cuttelod S, Thieband D, Burckardt P (1999) Effect of supplementation with vitamin D3 and calcium on quantitative ultrasound of bone in elderly institutionalized women: a longitudinal study. Osteoporosis Int 9:483\u2013488","journal-title":"Osteoporosis Int"},{"key":"157_CR21","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s001980200048","volume":"13","author":"S Gonnelli","year":"2002","unstructured":"Gonnelli S, Cepollaro C, Montagnani A, Martini S, Gennari L, Mangeri M, Gennari C (2002) Heel ultrasonography in monitoring alendronate therapy: a four-year longitudinal study. Osteoporos Int 13:415\u2013421","journal-title":"Osteoporos Int"},{"key":"157_CR22","doi-asserted-by":"crossref","unstructured":"Wuster C, Albanese C, De Aloysio D, Duboeuf F, Gambacciani M, Gonnelli S, Gluer CC, Hans D, Joly J, Reginster JY, De Terlizzi F, Cadossi R (2000) Phalangeal osteosonogrammetry study: age-related changes, diagnostic sensitivity, and discrimination power. The Phalangeal Osteosonogrammetry Study Group. J Bone Miner Res 15:1603\u20131614","DOI":"10.1359\/jbmr.2000.15.8.1603"},{"key":"157_CR23","doi-asserted-by":"crossref","unstructured":"Brownbill RA, Ilich JZ (2002) Validation of the use of the hand for estimating bone mineral density in other skeletal sites by DXA in healthy and osteoarthritic women. J Clin Densitom 5:273\u2013282","DOI":"10.1385\/JCD:5:3:273"},{"key":"157_CR24","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa035725","volume":"349","author":"JS Finkelstein","year":"2003","unstructured":"Finkelstein JS, Hayes A, Hunzelman JL, Wyland JJ, Lee H, Neer RM (2003) The effects of parathyroid hormone, alendronate, or both in men whit osteoporosis. N Engl J Med 349:1216\u20131226","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"157_CR25","first-page":"S32","volume":"18","author":"F Cosman","year":"2003","unstructured":"Cosman F, Nieves JW, Luckey MM, Zion M, Woelfert L, Lindsay R (2003) Daily versus cyclic PTH combined with alendronate versus alendronate alone for treatment of osteoporosis. J Bone Miner Res 18(Suppl 2):S32","journal-title":"J Bone Miner Res"},{"key":"157_CR26","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1210\/er.2004-0006","volume":"26","author":"AB Hodsman","year":"2005","unstructured":"Hodsman AB, Bauer DC, Dempster DW, Dian L, Hanley DA, Harris ST, Kendler DL, Mc Clung MR, Miller PD, Olszynski WP, Orwoll E, Yuen CK (2005) Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. Endocr Rev 26:688\u2013703","journal-title":"Endocr Rev"},{"key":"157_CR27","first-page":"2129","volume":"85","author":"RS Rittmaster","year":"2000","unstructured":"Rittmaster RS, Bolognese M, Ettinger MP, Hanley DA, Hodsman AB, Kendler DL, Rosen CJ (2000) Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate. J Clin Endocrinol Metab 85:2129\u20132134","journal-title":"J Clin Endocrinol Metab"},{"key":"157_CR28","doi-asserted-by":"crossref","first-page":"5212","DOI":"10.1210\/jc.2003-030768","volume":"88","author":"AB Hodsman","year":"2003","unstructured":"Hodsman AB, Hanley DA, Ettinger MP, Bolognese MA, Fox J, Metcalfe AJ, Lindsay R (2003) Efficacy and safety of human parathyroid hormone (1\u201384) in increasing bone mineral density in postmenopausal osteoporosis. J Clin Endocrinol Metab 88:5212\u20135220","journal-title":"J Clin Endocrinol Metab"},{"key":"157_CR29","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s001980070053","volume":"11","author":"R Barkmann","year":"2000","unstructured":"Barkmann R, Lusse S, Stampa B, Sakata S, Heller M, Gluer CC (2000) Assessment of the geometry of human finger phalanges using quantitative ultrasound in vivo. Osteoporos Int 11:745\u2013755","journal-title":"Osteoporos Int"},{"key":"157_CR30","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1359\/JBMR.040131","volume":"19","author":"S Sakata","year":"2004","unstructured":"Sakata S, Barkmann R, Lochmuller EM, Heller M, Gluer CC (2004) Assessing bone status beyond BMD: evaluation of bone geometry and porosity by quantitative ultrasound of human finger phalanges. J Bone Miner Res 19:924\u2013930","journal-title":"J Bone Miner Res"},{"key":"157_CR31","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1385\/JCD:8:3:278","volume":"8","author":"BM Ingle","year":"2005","unstructured":"Ingle BM, Machado AB, Pereda CA, Eastell R (2005) Monitoring alendronate and estardiol therapy with quantitative ultrasound (QUS) and bone mineral density. J Clin Densitom 8:278\u2013286","journal-title":"J Clin Densitom"},{"key":"157_CR32","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1121\/1.418118","volume":"101","author":"A Hosokawa","year":"1997","unstructured":"Hosokawa A, Otani T (1997) Ultrasonic wave propagation in bovine cancellous bone. J Acoust Soc Am 101:558\u2013562","journal-title":"J Acoust Soc Am"},{"key":"157_CR33","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1210\/jc.2002-021988","volume":"88","author":"BM Misof","year":"2003","unstructured":"Misof BM, Roschger P, Cosman F, Kurland ES, Tesch W, Messmer P, Dempster DW, Nieves J, Shane E, Fratzl P, Klaushofer K, Bilezikian J, Lindsay R (2003) Effects of intermittent parathyroid hormone administration on bone mineralization density in iliac crest biopsies from patients with osteoporosis: a paired study before and after treatment. J Clin Endocrinol Metab 88:1150\u20131156","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-006-0157-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-006-0157-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-006-0157-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T17:25:17Z","timestamp":1683480317000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-006-0157-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6,9]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["157"],"URL":"https:\/\/doi.org\/10.1007\/s00198-006-0157-3","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,6,9]]}}}